Financials data is unavailable for this security.
View more
Year on year Getinge AB had net income fall -3.17% from 2.49bn to 2.41bn despite a 12.49% increase in revenues from 28.29bn to 31.83bn. An increase in the cost of goods sold as a percentage of sales from 52.60% to 54.46% was a component in the falling net income despite rising revenues.
Gross margin | 45.80% |
---|---|
Net profit margin | 5.07% |
Operating margin | 8.65% |
Return on assets | 3.01% |
---|---|
Return on equity | 5.46% |
Return on investment | 4.00% |
More ▼
Cash flow in SEKView more
In 2023, cash reserves at Getinge AB fell by 2.95bn. However, the company earned 2.96bn from its operations for a Cash Flow Margin of 9.29%. In addition the company generated 511.00m cash from financing while 6.54bn was spent on investing.
Cash flow per share | 13.50 |
---|---|
Price/Cash flow per share | 13.43 |
Book value per share | 111.09 |
---|---|
Tangible book value per share | -24.10 |
More ▼
Balance sheet in SEKView more
Current ratio | 1.07 |
---|---|
Quick ratio | 0.5965 |
Total debt/total equity | 0.3592 |
---|---|
Total debt/total capital | 0.2629 |
More ▼
Growth rates in SEK
Year on year, growth in dividends per share increased 3.53% while earnings per share excluding extraordinary items fell by -3.17%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized dividend per share growth ranks highest in its industry.
Div yield(5 year avg) | 1.43% |
---|---|
Div growth rate (5 year) | 34.49% |
Payout ratio (TTM) | 70.85% |
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | -24.84 |
More ▼